1. Different scaling and root planing strategies in Turkish patients with aggressive periodontitis: A randomized controlled clinical trial
- Author
-
Dilek Mamaklıoğlu, Maribasappa Karched, Leyla Kuru, Bahar Kuru, Sirkka Asikainen, Başak Doğan, and Mamaklioglu D., Karched M., KURU L., Kuru B., Asikainen S., DOĞAN B.
- Subjects
Dental Assisting ,CREVICULAR FLUID ,Diş Hekimliği (çeşitli) ,Orthodontics ,Diş Hijyeni ,Sağlık Bilimleri ,interleukin-1 beta ,THERAPY ,Clinical Medicine (MED) ,CLASSIFICATION ,Root Planing ,interleukin-17 ,ONE-STAGE ,Diş Hekimliği ,periodontal debridement ,Health Sciences ,Humans ,Ortodonti ,Klinik Tıp (MED) ,Dentistry (miscellaneous) ,EARLY-ONSET PERIODONTITIS ,bacteria ,CHRONIC ADULT ,General Dentistry ,ULTRASONIC DEBRIDEMENT ,Klinik Tıp ,DENTISTRY, ORAL SURGERY & MEDICINE ,Periodontoloji ,Ağız Cerrahisi ,Gingival Crevicular Fluid ,CLINICAL MEDICINE ,FULL-MOUTH DISINFECTION ,aggressive periodontitis ,Tıp ,DİŞ HEKİMLİĞİ, ORAL CERRAHİ VE TIP ,PERI-IMPLANT DISEASES ,Dentistry ,Chronic Periodontitis ,Dental Hygiene ,Dental Scaling ,Medicine ,Dişçilik Hizmetleri ,Periodontics ,Oral Surgery ,TH17 CELLS - Abstract
Objectives The aim of this study was to compare clinical, cytokine and microbiological responses after quadrant-based scaling and root planing (Q-SRP), full-mouth SRP (FM-SRP) and full-mouth disinfection (FMD) in patients with generalized aggressive periodontitis (GAgP), which is currently termed as generalized stage-III and grade-C periodontitis. Methods Forty-two patients with GAgP were randomly assigned into groups as Q-SRP, FM-SRP or FMD with chlorhexidine. Clinical parameters were recorded, and gingival crevicular fluid (GCF) and subgingival plaque samples were collected at baseline, 3 and 6 months after treatment. GCF levels of interleukin (IL)-1 beta and IL-17 were analysed using ELISA. Quantities of six bacterial species were determined using qPCR. Results Clinical parameters improved significantly in all groups at 3 and 6 months (p 6 mm was lower in the FMD than Q-SRP group at 3 and 6 months (p < 0.05). FMD showed significantly higher percentage of pocket closure compared with Q-SRP and FM-SRP at both 3 and 6 months after treatment (p < 0.05). The IL-1 beta levels decreased only in the FMD group (p < 0.05), whereas no changes were found in IL-17 levels in any group. The levels of five out of six bacterial species decreased at 3 and/or 6 months only in the FMD group (p < 0.05). Conclusions The FMD treatment appears to offer superior outcome than Q-SRP and could be the first choice for patients with GAgP.
- Published
- 2022
- Full Text
- View/download PDF